McMinn Rachel bought NGNE
September 22, 2026 · Form 4 insider transaction
McMinn Rachel bought 756 shares of Neurogene Inc. at $25.32 per share, a transaction worth $19.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
756
Price
$25.32
Total value
$19.1K
InsiderMcMinn Rachel
Role—
CompanyNeurogene Inc. (NGNE)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 22, 2026
Filing dateOctober 2, 2026
Shares owned after1,345,063
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes (a) 15,933 restricted stock units that vest annually in equal installments on March 23, 2027 and March 23, 2028; and (b) 25,900 restricted stock units that vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029.